What Happened?
Hayward, CA-based Anthera Pharmaceuticals has promoted Debra Odink as Chief Technology Officer.
About the Company
Anthera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including exocrine pancreatic insufficiency due to cystic fibrosis, lupus, lupus with glomerulonephritis, and IgA nephropathy.
About the Person
Previously Odink was senior vice president of pharmaceutical research and development at Anthera Pharmaceuticals.
Info Source
News
Short Profile